Search

Your search keyword '"Viatris Inc. -- Forecasts and trends"' showing total 3 results
Start Over Descriptor "Viatris Inc. -- Forecasts and trends" Publisher business wire, inc.
3 results on '"Viatris Inc. -- Forecasts and trends"'

1. $4.2 Billion Overactive Bladder Treatment (OAB) Markets - Global Forecasts to 2027: Growing R&D Investments and the Launch of Novel Therapies in the Coming Years - ResearchAndMarkets.com

Subjects
Pfizer Inc. -- Forecasts and trends, AbbVie Inc. -- Forecasts and trends, Viatris Inc. -- Forecasts and trends, Options (Finance) -- Forecasts and trends -- Reports, Mirabegron -- Forecasts and trends -- Reports, Urinary incontinence -- Forecasts and trends -- Reports, Darifenacin -- Reports -- Forecasts and trends, Market trend/market analysis, Business, Business, international
Abstract

DUBLIN -- The 'Overactive Bladder Treatment (OAB) Market by Drug type ( Anticholinergic (Solifenacin, Oxybutynin, Tolterodine, Darifenacin), Mirabegron), Botox, Neuromodulation, Disease Type (Idopathic OAB and Neurogenic OAB) and Region - [...]

Published
2022

2. Antiparasitic Drugs Global Market Report 2022: Government, Non-Profit and Market Player Initiatives to Boost Adoption Bode Well For Growth - ResearchAndMarkets.com

Subjects
Cadila Pharmaceuticals -- Forecasts and trends, Merck KGaA -- Forecasts and trends, GSK PLC -- Forecasts and trends, Cipla Ltd. -- Forecasts and trends, Glenmark Pharmaceuticals Ltd. -- Forecasts and trends, Viatris Inc. -- Forecasts and trends, Novartis AG -- Forecasts and trends, Sun Pharmaceutical Industries Ltd. -- Forecasts and trends, Dr. Reddy's Laboratories Ltd. -- Forecasts and trends, Parasitic diseases -- Forecasts and trends, Drugs -- Forecasts and trends, Market trend/market analysis, Business, Business, international
Abstract

DUBLIN -- The 'Antiparasitic Drugs Market, by Product Type, by Route of Administration, by Application, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030' report has [...]

Published
2022

3. Global Alzheimer's Therapeutics Market Report (2022 to 2032) - Players Include Macleods Pharmaceuticals, Viatris, Lupin and Cipla - ResearchAndMarkets.com

Subjects
Janssen Pharmaceuticals Inc. -- Forecasts and trends, Johnson & Johnson -- Forecasts and trends, Aurobindo Pharma Ltd. -- Forecasts and trends, Viatris Inc. -- Forecasts and trends, Cipla Ltd. -- Forecasts and trends, AbbVie Inc. -- Forecasts and trends, Novartis AG -- Forecasts and trends, Sun Pharmaceutical Industries Ltd. -- Forecasts and trends, Torrent Pharmaceuticals Ltd. -- Forecasts and trends, Teva Pharmaceutical Industries Ltd. -- Forecasts and trends, Eisai Company Ltd. -- Forecasts and trends, Dr. Reddy's Laboratories Ltd. -- Forecasts and trends, Alzheimer's disease -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Market trend/market analysis, Business, Business, international
Abstract

DUBLIN -- The 'Alzheimer's Therapeutics Market 2022-2032' report has been added to ResearchAndMarkets.com's offering. This report offers a global industry analysis for 2017-2021 and an opportunity assessment for 2022-2032. Companies [...]

Published
2022

Catalog

Books, media, physical & digital resources
See catalog results